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At the height of World War I, the human population was
assaulted by a powerful, but very small, foreign agent that rapidly
appeared seemingly from nowhere. Ultimately identified as the
‘‘Spanish flu’’, this agent wreaked havoc on anyone in its path.
Prostrating vast numbers of victims worldwide with severe
pneumonia, which often progressed to a fatal outcome, the
‘‘Spanish flu’’ caused an estimated 20–50 million deaths
worldwide [1]. The resultant 1918 pandemic was one of the most
formidable foes faced by humankind. In this brief review, we
discuss some recent insights into the pathogenicity of its causative
agent, the 1918 pandemic influenza virus.
The ‘‘Spanish’’ Influenza Pandemic of 1918–1919
In early March of 1918, several severe cases of influenza were
reported in the United States. This would mark the beginning of the
first wave of the ‘‘Spanish’’ influenza pandemic (reviewed in [1]). As
massive numbers of US military troops were deployed in Europe,
the virus spread too, leading to outbreaks throughout the United
States, Europe, and possibly Asia. Spain was neutral during the war
and its press was therefore uncensored. Accordingly, the Spanish
newspapers were filled with reports of the disease, especially when
the king became ill. It is believed that these published accounts of
the spread of the disease explain why the virus became known as the
‘‘Spanish’’ influenza. During the first wave of this, like other,
pandemics, mortality rates were in the normal range, though
morbidity rates were high. However, while the first wave killed
relatively few, by the time the next wave came, in the fall of 1918,
the virus had undergone numerous passages through humans, had
changed dramatically, and was now lethal. Together with a third
wave, which occurred in the winter of 1918–1919, approximately
30% of the world’s population (500 million people) is thought to
have been clinically affected by the 1918 pandemic [1]. Unexpect-
edly, the 1918 pandemic attacked particularly young adults, who
usually have a low death rate during influenza epidemics. As a
result, influenza and pneumonia death rates for 15- to 34-year-olds
were more than 20 times higher in 1918 than in the previous year
(the mortality rate associated with the 1918 virus was more than
2.5% among infected persons compared with less than 0.1% in
other influenza epidemics; [1]). Most deaths were caused from
secondary bacterial pneumonia due to a lack of antibiotics [1]. The
1918 pandemic virus, however, also killed quickly and directly with
a violent viral pneumonia, often with either massive acute
pulmonary hemorrhage or pulmonary edema. The disease course
was frequently less than 5 days [1].
Efforts to Unmask the Deadly 1918 Pandemic
Virus
The identity of the 1918 pandemic virus remained a mystery in
the absence of technology to isolate viruses. By the early 1930s,
American and British researchers succeeded in establishing a
system to isolate swine and human influenza viruses [2,3]. With
this ‘‘new’’ technique in hand, researchers in the 1950s tried to
isolate the 1918 pandemic virus from victims of the pandemic who
were buried in permafrost graves in Alaska. However, they were
unable to recover virus from the available specimens.
In the late 1990s, the development of molecular biotechnology
brought about a breakthrough. Taubenberger’s group at the US
Armed Forces Institute of Pathology succeeded in isolating viral
genome RNA fragments from formalin-fixed, paraffin-embedded
autopsy tissues of American army soldiers who had died in the 1918
pandemic [4]. They also isolated viral RNAs from an Alaskan Inuit
woman who had been buried in permafrost in Alaska [5]. With
these samples, they were able to determine the coding sequences of
alleightRNAsegmentsofthe1918pandemicvirus[4–10].This10-
year endeavor finally led them to identify the pathogenic agent that
had caused the great 1918 pandemic: that is, influenza A virus
subtypeH1N1.Furthersequencinganalysessuggested thatthe 1918
virus may be of avian origin and transmitted from birds to humans
directly or indirectly, although this is remains controversial. In the
process of adaptation to humans through mutations, the 1918 virus
is thought to have acquired its high virulence.
The Resurrection of the ‘‘Spanish’’ Influenza Virus
Although the complete sequences of the viral RNAs of the 1918
pandemic virus have been determined, the viral genome does not
contain any motifs known to be associated with high virulence [5].
Therefore, to understand the extraordinary virulence of the 1918
pandemic virus, it was important to re-create the virus and examine
its pathogenicity in animals. The recent technological advancement
of reverse genetics, which allows the generation of infectious
influenza viruses entirely from cDNAs [11], made possible the re-
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Centers for Disease Control and Prevention [12] and we [13]
succeeded in rescuing viruses bearing all eight RNA segments of the
1918 virus by using reverse genetics. Now that we had all of the
materials required, we could study the molecular properties
associated with the unusual virulence of the 1918 pandemic virus.
Aberrant Immune Responses in Animals Infected
with the Reconstructed 1918 Virus
To derive a molecular mechanism of pathogenicity for the 1918
virus, the reconstructed 1918 virus was characterized in mouse and
non-human primate models [12–14]. In the infected animals, the
1918 virus replicated to high levels and spread rapidly throughout
the respiratory tract. Severe damage, including extensive edema and
hemorrhagic exudates, was observed in the lungs of the virus-
infected animals [13], as reported for patients who succumbed to the
‘‘Spanish’’ influenza, leading to acute respiratory distress and death
(Figure 1). Host responses to the 1918 virus were also investigated by
using microarray technology [13,14]. Strikingly, infection of non-
human primates with the 1918 virus triggered high, sustained
expression of genes involved in innate immune responses, such as
proinflammatory cytokines and chemokines [13]. On the other
hand, the virus induced fewer type I interferon genes [13], likely
leading to enhanced viral replication. Such uncontrolled innate
immune responses have also been observed in mice inoculated with
the 1918 virus [14] and in hosts infected with avian H5N1 influenza
viruses. These findings suggest that strong immune responses are a
hallmark of highly pathogenic influenza virus infections.
Determinants of the High Virulence of the 1918
Virus in Animals
Which viral factor(s) contribute to the extraordinary virulence of
the 1918 virus? One of the key players is hemagglutinin (HA),
which is the viral surface glycoprotein that has two functions in the
early stage of virus replication: receptor binding and membrane
fusion. The HAs of highly pathogenic avian influenza viruses play
a critical role in virulence as they typically contain a specific motif
(i.e., a series of basic amino acids at the cleavage site [15,16]) that
contributes to pathogenicity. This motif, however, is not found in
the 1918 HA sequence. Nonetheless, we and others demonstrated
Figure 1. Pathogenicity of the 1918 pandemic influenza virus in non-human primates. Taubenberger’s group isolated viral genome RNA
fragments from formalin-fixed, paraffin-embedded autopsy tissue from victims of the 1918 pandemic and determined the coding sequences of all
eight RNA segments of the 1918 pandemic virus. Based on these sequences, a virus bearing all eight RNA segments of the 1918 virus was generated
by reverse genetics and its pathogenicity was determined in a non-human primate model. The 1918 virus caused a highly pathogenic respiratory
infection in non-human primates that culminated in acute respiratory distress and a fatal outcome. The infected animals mounted an immune
response, characterized by dysregulation of the antiviral response, indicating that atypical host innate immune responses may contribute to lethality.
The infection of nonhuman primates with the 1918 pandemic virus caused severe damage in the lungs (a), whereas no appreciable lesions were
observed in the lungs of animals infected with a contemporary human H1N1 virus (b).
doi:10.1371/journal.ppat.1001218.g001
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background of a contemporary human virus replicated to a high
titer in the lungs and caused severe lung damage accompanied by
a significant influx of neutrophils and alveolar macrophages into
the lung [17,18] (Figure 2). Similar findings were observed with
the authentic 1918 virus [19] with severe morbidity and eventual
death. These results suggest a critical role for the HA gene in the
pathogenicity of the 1918 virus. The region(s) of HA responsible
for high virulence has not yet been identified; however,
Taubenberger’s group has demonstrated that HA receptor
binding specificity plays a role in pathogenesis in mice, although
their results also suggest the presence of additional virulence
determinant(s) [20]. The importance of the 1918 HA, especially
two amino acids that are responsible for receptor binding
specificity [21] and efficient virus transmission, has also been
demonstrated in ferrets [22,23].
The other important player in the virulence of the 1918 virus is
the viral RNA polymerase complex. A unique feature of the 1918
pandemic was that many people died from viral pneumonia;
human influenza viruses typically replicate poorly in the lungs of
infected individuals and rarely cause fatal viral pneumonia. We
reported efficient replication of the 1918 virus in the lungs of
infected ferrets and non-human primates, which led to viral
pneumonia [13,24]. In contrast, a contemporary human H1N1
virus was not detected in the lungs of infected animals, although it
replicated in the nasal turbinates. Hence, we assume that the
ability of the 1918 virus to grow in the lungs is associated with its
high virulence in humans. We also found that high virus titers in
the lungs of infected ferrets were dependent on the 1918
polymerase and NP genes (Figure 3) [24]. The importance of
the polymerase genes in pathogenicity in mice [25] and
transmission in ferrets [22] was also shown. These findings
strongly implicate the viral RNA polymerase complex in the
efficient spread of virus to the lower respiratory tract and suggest it
may be required, together with a specific HA, to induce the type of
fatal pneumonia encountered during the 1918–1919 pandemic.
Other viral factors may also be involved in the pathogenicity of
the 1918 pandemic virus, such as PB1-F2, NA, and NS1 [25–28].
PB1-F2, a proapoptotic viral protein, requires only a single amino
acid change at position 66 to increase the pathogenicity of the
1918 virus [26]. Expression of the 1918 PB1-F2 promotes lung
pathology in primary viral infection and secondary bacterial
infection [27]. A potential role for the NA gene in optimal
replication and virulence of the 1918 virus has also been suggested
[25]. For NS1, an antagonist of cellular innate immune defenses,
the 1918 protein is better able to block the expression of IFN-
regulated genes than is the NS1 protein of other human influenza
viruses [28]. Moreover, the C-terminal of NS1 is known to
contribute to enhanced virulence and pathogenesis by a
mechanism distinct from its IFN-antagonistic properties [29].
Despite these important functions of NS1, substitution of the NS
gene of the 1918 virus for that of a parental virus caused
attenuation of the parental virus in mice [10,25].
Concluding Remarks
The first influenza pandemic of the 21st century was caused by
a novel swine-origin H1N1 influenza virus that emerged in early
2009. This virus is substantially less virulent than the 1918
influenza virus, but it has the potential to acquire amino acid
changes in its viral proteins that would increase its pathogenicity.
To prepare for such events and future pandemics, we need to
understand the molecular basis of the high-virulence phenotype of
the 1918 pandemic virus to help identify virulence factors in other
emerging pandemic viruses. Additionally, the fact that more than
97% of the people infected with the 1918 virus survived raises the
intriguing possibility of some contribution of host genetics to the
consequences of influenza (i.e., survival or death). Thus, it is also
important to explore host factors that are involved in resistance or
susceptibility to influenza virus infection. Such information could
accelerate the development of new antiviral drugs for prophylaxis
and treatment, which are urgently needed given the obstacles to
rapid development of an effective vaccine against pandemic
influenza.
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